Ovarian cancer, Gynecology, Internal medicine, Case-control study and Odds ratio are his primary areas of study. Daniel W. Cramer has researched Ovarian cancer in several fields, including Ovary, Serous fluid and Risk factor. His work deals with themes such as Cancer research, Serous carcinoma, Clear cell, Young adult and Adenocarcinoma, which intersect with Serous fluid.
His biological study spans a wide range of topics, including Epidemiology, Family history, Infertility and Obstetrics. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Oncology and Physiology. His Odds ratio research incorporates elements of Gastroenterology, Mammary gland, Confidence interval, Tubal ligation and Aspirin.
His primary areas of study are Ovarian cancer, Internal medicine, Gynecology, Oncology and Case-control study. His studies in Ovarian cancer integrate themes in fields like Odds ratio, Single-nucleotide polymorphism, Genotype and Serous fluid. His work is dedicated to discovering how Internal medicine, Endocrinology are connected with Physiology and other disciplines.
His work in Gynecology addresses subjects such as Obstetrics, which are connected to disciplines such as Pregnancy. The various areas that Daniel W. Cramer examines in his Oncology study include Cohort study, Bioinformatics, Ovarian carcinoma, Immunology and Biomarker. Daniel W. Cramer interconnects Relative risk, Tubal ligation and Cohort in the investigation of issues within Case-control study.
Daniel W. Cramer mainly focuses on Ovarian cancer, Internal medicine, Oncology, Odds ratio and Case-control study. His research integrates issues of Serous fluid, Confidence interval, Obstetrics, Antibody and Cohort in his study of Ovarian cancer. His research links Genetic association with Internal medicine.
His Oncology research is multidisciplinary, incorporating elements of Body mass index, Genome-wide association study, Single-nucleotide polymorphism, Cohort study and Hormone therapy. His Odds ratio research includes elements of Logistic regression, Genotype, Cancer prevention, Confounding and Adenocarcinoma. His Case-control study study combines topics from a wide range of disciplines, such as Biomarker, Cancer and Prospective cohort study.
Daniel W. Cramer spends much of his time researching Ovarian cancer, Cancer research, Context, Serous fluid and Case-control study. His Ovarian cancer research integrates issues from Oncology and Obstetrics. He combines subjects such as Obesity and Epidemiology with his study of Oncology.
His Cancer research research includes themes of Cancer, Genome-wide association study, DNA methylation, Transcription factor and microRNA. The study incorporates disciplines such as Odds ratio, Lower risk, Pancreatic duct, KRAS and Germ cell in addition to Serous fluid. His Case-control study study combines topics in areas such as Cohort study, Autoantibody, Ovarian cancer early detection, Immunology and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
Nature (2011)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee;A Miron;R Drapkin;M R Nucci.
The Journal of Pathology (2007)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros;Michael G Muto;Yonghee Lee;Julia A Elvin.
The American Journal of Surgical Pathology (2006)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)
Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis
Daniel W. Cramer;William R. Welch.
Journal of the National Cancer Institute (1983)
CIGARETTE SMOKING, RELATIVE WEIGHT, AND MENOPAUSE
Walter Willett;Walter Willett;Meir J. Stampfer;Meir J. Stampfer;Christopher Bain;Christopher Bain;Robert Lipnick.
American Journal of Epidemiology (1983)
The Epidemiology of Endometriosis
Daniel W. Cramer;Stacey A. Missmer.
Annals of the New York Academy of Sciences (2002)
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Jae Hoon Kim;Steven J. Skates;Toshimitsu Uede;Kwong Kwok Wong.
JAMA (2002)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cedars-Sinai Medical Center
Emory University
Harvard University
University of Southern California
Duke University
The University of Texas at Austin
German Cancer Research Center
University of New South Wales
University of Copenhagen
QIMR Berghofer Medical Research Institute
University of Sydney
Texas A&M University
University of Waterloo
Raytheon (United States)
University of Barcelona
Centre national de la recherche scientifique, CNRS
University of Montana
University of California, Berkeley
New York University
Northwestern University
University of Salerno
Salk Institute for Biological Studies
Université Catholique de Louvain
Hebrew University of Jerusalem
Cornell University
California Institute of Technology